We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex ... Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. Show more
IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to...
IRVINE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to...
Generated $24.7 million in net product sales of XDEMVY®, an 89% increase over Q4 2023, and delivered approximately 26,000 bottles of XDEMVY to patients Secured multiple commercial payer contracts...
| Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.97 | -7.23466764598 | 27.23 | 27.89 | 24.94 | 652078 | 26.01200787 | CS |
| 4 | -10.1 | -28.5633484163 | 35.36 | 36.73 | 24.94 | 647619 | 30.12966421 | CS |
| 12 | -11.22 | -30.7565789474 | 36.48 | 42.5 | 24.94 | 578326 | 33.55346145 | CS |
| 26 | 5.1 | 25.2976190476 | 20.16 | 42.5 | 18.99 | 677902 | 31.47666745 | CS |
| 52 | 7.99 | 46.2651997684 | 17.27 | 42.5 | 12.57 | 598725 | 25.29007569 | CS |
| 156 | -4.62 | -15.4618473896 | 29.88 | 42.5 | 10.8001 | 265620 | 23.0180493 | CS |
| 260 | 6.96 | 38.0327868852 | 18.3 | 63.69 | 10.8001 | 229846 | 23.71026691 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
